Dapagliflozin EP Impurity A
| VS CAT No | VS-D015001 |
| CAS No | 1807632-95-6 |
| Mol.F. | C21H25BrO6 |
| Mol.Wt. | 453.3 |
| Inv. Status | Custom Synthesis |
Chemical Name: (1S)-1,5-anhydro-1-C-[4-bromo-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (as per EP) ; (2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (as per USP)
Synonym: Dapagliflozin USP Related Compound A ; Dapagliflozin 4-Bromo Analog ; Dapagliflozin Impurity-S3C (Bromo Dapagliflozin)
Shipping Temperature: Ambient
Country of Origin: India
Smiles: O[C@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Br)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1Oc
Dapagliflozin EP Impurity A is chemically (1S)-1,5-anhydro-1-C-[4-bromo-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (as per EP) ; (2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (as per USP). It is also known as Dapagliflozin USP Related Compound A ; Dapagliflozin 4-Bromo Analog ; Dapagliflozin Impurity-S3C (Bromo Dapagliflozin). Dapagliflozin EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Dapagliflozin EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dapagliflozin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. Vsquare products are for analytical purpose only and not for human use.